| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.07 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.07 |